FI972442A0 - Liukenemista edistävä aine hydrofiilisille makromolekyyleille - Google Patents

Liukenemista edistävä aine hydrofiilisille makromolekyyleille

Info

Publication number
FI972442A0
FI972442A0 FI972442A FI972442A FI972442A0 FI 972442 A0 FI972442 A0 FI 972442A0 FI 972442 A FI972442 A FI 972442A FI 972442 A FI972442 A FI 972442A FI 972442 A0 FI972442 A0 FI 972442A0
Authority
FI
Finland
Prior art keywords
promoting agent
hydrophilic macromolecules
preparation
resolution
resolution promoting
Prior art date
Application number
FI972442A
Other languages
English (en)
Swedish (sv)
Other versions
FI972442A (fi
Inventor
Roger Randal Charles New
Christopher John Kirby
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of FI972442A0 publication Critical patent/FI972442A0/fi
Publication of FI972442A publication Critical patent/FI972442A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lift Valve (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • General Preparation And Processing Of Foods (AREA)
FI972442A 1994-12-09 1997-06-09 Liukenemista edistävä aine hydrofiilisille makromolekyyleille FI972442A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9424902.6A GB9424902D0 (en) 1994-12-09 1994-12-09 Solubilisation Aids
PCT/GB1995/002891 WO1996017593A1 (en) 1994-12-09 1995-12-08 Solubilisation aids for hydrophilic macromolecules

Publications (2)

Publication Number Publication Date
FI972442A0 true FI972442A0 (fi) 1997-06-09
FI972442A FI972442A (fi) 1997-06-09

Family

ID=10765694

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972442A FI972442A (fi) 1994-12-09 1997-06-09 Liukenemista edistävä aine hydrofiilisille makromolekyyleille

Country Status (14)

Country Link
US (1) US5968549A (fi)
EP (1) EP0796085B1 (fi)
JP (1) JPH10510256A (fi)
CN (1) CN1169113A (fi)
AT (1) ATE192920T1 (fi)
AU (1) AU4122496A (fi)
CA (1) CA2207279A1 (fi)
DE (1) DE69517048T2 (fi)
FI (1) FI972442A (fi)
GB (1) GB9424902D0 (fi)
IL (1) IL116313A0 (fi)
NO (1) NO972608L (fi)
WO (1) WO1996017593A1 (fi)
ZA (1) ZA9510508B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9521806D0 (en) * 1995-10-25 1996-01-03 Cortecs Ltd Preservation methods
TW518219B (en) 1996-04-26 2003-01-21 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
GB9613858D0 (en) * 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JP2002515757A (ja) * 1997-02-07 2002-05-28 ケイ・アイ化成株式会社 水媒介による、安定なビタミンｃ誘導体の強化によって、水生生物の成長及び生存率を高める方法
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
CN1329502A (zh) * 1998-12-04 2002-01-02 普罗瓦利斯英国有限公司 含有胰岛素的药物组合物
US7169889B1 (en) * 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
EP1731139A4 (en) * 2004-03-31 2008-12-03 Aspion Co Ltd PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR
RU2424792C2 (ru) 2004-05-03 2011-07-27 Хермес Байесайенсиз, Инк. Липосомы, используемые для доставки лекарственных средств
PL1773878T3 (pl) 2004-07-19 2015-07-31 Biocon Ltd Koniugaty insulina-oligomer, ich formulacje i zastosowania
US20090238846A1 (en) * 2004-08-31 2009-09-24 Aspion Co., Ltd. S/O type external preparation
US20070104780A1 (en) * 2005-10-25 2007-05-10 Lipari John M Formulation comprising a drug of low water solubility and method of use thereof
KR101234540B1 (ko) 2007-10-16 2013-02-19 바이오콘 리미티드 경구 투여가능한 고형 약제학적 조성물 및 그 제조방법
US9421236B2 (en) 2010-12-17 2016-08-23 Johnson & Johnson Consumer Inc. Compositions comprising Lilium siberia extracts and uses thereof
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
BR122021024957B1 (pt) 2015-10-16 2023-12-12 Ipsen Biopharm Ltd Processos de produção de uma composição de irinotecano lipossômico estabilizado em armazenamento
KR102067094B1 (ko) * 2018-04-17 2020-01-15 김철환 비(非)계면활성제형 오일-물(o/w) 분산 조성물, 비(非)계면활성제형 물-오일(w/o) 분산 조성물 및 이들의 제조방법
CN110215740B (zh) * 2019-07-15 2021-05-04 大连医科大学 一种两性离子亲水前处理硅胶材料的制备方法
CN111888475B (zh) * 2020-07-24 2022-01-07 华中科技大学 缓控释制剂及制法与制备原位肿瘤免疫联合治疗药物应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
NO972608D0 (no) 1997-06-06
CA2207279A1 (en) 1996-06-13
US5968549A (en) 1999-10-19
IL116313A0 (en) 1996-03-31
DE69517048T2 (de) 2000-09-14
DE69517048D1 (de) 2000-06-21
FI972442A (fi) 1997-06-09
GB9424902D0 (en) 1995-02-08
JPH10510256A (ja) 1998-10-06
MX9704274A (es) 1997-09-30
EP0796085A1 (en) 1997-09-24
WO1996017593A1 (en) 1996-06-13
CN1169113A (zh) 1997-12-31
EP0796085B1 (en) 2000-05-17
NO972608L (no) 1997-08-08
AU4122496A (en) 1996-06-26
ZA9510508B (en) 1997-06-11
ATE192920T1 (de) 2000-06-15

Similar Documents

Publication Publication Date Title
FI972442A (fi) Liukenemista edistävä aine hydrofiilisille makromolekyyleille
BR9916894A (pt) ácidos sulfohidroxâmicos e sulfohidroxamatos eseu uso como inibidores de mek
DE69835366D1 (de) Verfahren zur herstellung von perfluorvinylethersulfonsäure-derivaten
OA08170A (fr) Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues.
DE3854854D1 (de) 3-Desmethyl-mevalonsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen, ihre Verwendung sowie Zwischenprodukte
BR0007589A (pt) Inibidores da proliferação de células
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
BR9709845B1 (pt) preparaÇço aquosa de insulina, formulaÇço farmacÊutica parenteral, e, processso para aumentar a estabilidade quÍmica de uma preparaÇço de insulina.
DE59711908D1 (de) Verfahren zur Herstellung von Salzen von Säuregruppen tragenden pharmazeutischen Wirkstoffen
DE69431373D1 (de) Verfahren zur Herstellung von optisch aktiven 2-Amino-1-Phenylethanol-Derivaten
DK0792165T3 (da) Immunogene præparater
DE69906849D1 (de) Verfahren zur Herstellung von optisch aktiven Phenylpropionsäure-Derivat
ATE183188T1 (de) Cephalosporinderivative und verfahren zu ihrer herstellung
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
NO883074L (no) Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater.
DE69815179D1 (de) Verfahren zur Herstellung von D-Glucoronsäurelacton
DE69801302T2 (de) Verfahren zur Herstellung fester Lösungen von Chinacridonen
AU9080398A (en) Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
BR9604843A (pt) Peptìdeo e derivado do mesmo, e, droga e composição para tratar osteopatia
ATE31624T1 (de) Galenische form fuer amitriptylinoxid und verfahren zur herstellung.
DE60002486D1 (de) 1,4-dihydropyridin-5-carbonsäureester-derivate und verfahren zu ihrer herstellung
ATE53001T1 (de) Verfahren zur herstellung von optisch aktiven hydrochinonderivaten, sowie von d-alphatocopherol.
UA29770A (uk) Спосіб пригнічення репродукції вірусу імунодефіциту людини
RU94026088A (ru) Способ лечения шока и способ ингибирования продуцирования альфа фактора некроза опухоли

Legal Events

Date Code Title Description
FD Application lapsed